NOS2 and inflammatory response: Inhalation of 12.5 or 25 mg/ml ketamine markedly suppressed OVA-provoked airway hyperreactivity (AHR), airway inflammation and airway inflammatory cell infiltration into BALF, and significantly decreased OVA-induced up-regulation of iNOS, IL-4 and NO.